Insight in obsessive compulsive disorder and body dysmorphic disorder☆
To access this article, please choose from the options below
☆ Supported in part by Pfizer Pharmaceuticals (J.L.E.) and by a National Institute of Mental Health grant (R29-MH54841) and an unrestricted grant from Solvay Pharmaceuticals and Pharmacia and Upjohn to K.A.P.
PII: S0010-440X(03)00172-X
doi:10.1016/j.comppsych.2003.09.010
© 2004 Elsevier Inc. All rights reserved.
